Reckitt Benckiser Group (CHIX:RKTL) Research & Development: £0 Mil (TTM As of Dec. 2025)


CHIX:RKTL Reckitt Benckiser Group PLC CHIX:RKTL
73 GF Score
Price £48.31
GF Value £54.07
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Reckitt Benckiser Group Research & Development?

Reckitt Benckiser Group CHIX:RKTL +1.39% 73 Research & Development is £0 Mil as of Dec. 2025. GuruFocus rates CHIX:RKTL with a GF Score™ of 73/100 and a GF Value™ of £54.07 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Reckitt Benckiser Group's Research & Development for the six months ended in Dec. 2025 was £0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £0 Mil.

Reckitt Benckiser Group  (CHIX:RKTl) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Reckitt Benckiser Group Research & Development Related Terms

Reckitt Benckiser Group Research & Development Historical Data

* Premium members only.

The historical data trend for Reckitt Benckiser Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reckitt Benckiser Group Research & Development Chart

Reckitt Benckiser Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 313.00 325.00 337.00 325.00 316.00

Reckitt Benckiser Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:RKTL
73GF Score
Reckitt Benckiser Group PLC CHIX:RKTL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reckitt Benckiser Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0 Mil mean?
Reckitt Benckiser Group (CHIX:RKTL) has a Research & Development of £0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Reckitt Benckiser Group and its competitors.
Is Reckitt Benckiser Group's Research & Development too high?
Reckitt Benckiser Group's current Research & Development is £0 Mil. Overall, Reckitt Benckiser Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Reckitt Benckiser Group's Research & Development compare to PG and CL?
Reckitt Benckiser Group's Research & Development of £0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Reckitt Benckiser Group and its competitors. Reckitt Benckiser Group's current Research & Development is £0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reckitt Benckiser Group stock overvalued right now?
Based on GuruFocus' analysis, Reckitt Benckiser Group (CHIX:RKTL) is currently considered Modestly Undervalued. The stock's GF Value™ is £54.07, compared to a current price of £48.31 — trading 10.7% below its estimated fair value. The current Research & Development is £0 Mil. Reckitt Benckiser Group's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Reckitt Benckiser Group (CHIX:RKTL), the current Research & Development is £0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Reckitt Benckiser Group (CHIX:RKTL) Overvalued in 2026?

Based on GuruFocus' analysis, Reckitt Benckiser Group stock appears to be undervalued. The current stock price of £48.31 is trading 10.7% below its estimated GF Value™ of £54.07. GuruFocus considers Reckitt Benckiser Group to be Modestly Undervalued.

Key valuation signals for CHIX:RKTL:

  • Research & Development: £0 Mil
  • GF Value™: £54.07 vs. price of £48.31 (10.7% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the CHIX:RKTL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Reckitt Benckiser Group Business Description

Address 103-105 Bath Road, Slough, Berkshire, GBR, SL1 3UH
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold a number-one or number-two position in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating over 40% of core sales from emerging markets.
73GF Score

Get the complete analysis for CHIX:RKTL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£48.31
Price
£54.07
GF Value